CTOs on the Move

IARP Headquarters

www.iarp.org

 
IARP Headquarters is a Santa Cruz, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.iarp.org
  • 3540 Soquel Ave Ste A
    Santa Cruz, CA USA 95062
  • Phone: 831.464.4892

Executives

Name Title Contact Details

Similar Companies

Continuing Ed Courses

Continuing Ed Courses is a Poway, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Straumann USA

Straumann USA LLC is a Andover, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthPlan Services

HealthPlan Services (HPS) is the nation’s largest independent provider of sales, benefits administration, retention, reform and technology solutions to the insurance and managed care industries. Headquartered in Tampa, Florida, HPS was founded in 1970 and employs 1,500+ associates. HPS stands at the forefront of the insurance industry, providing exchange connectivity, administration, distribution and technology services to insurers of individual, small group, voluntary and association plans, as well as valuable solutions to thousands of brokers and agents, nationwide. Our Go-To-Exchange® platform combines the services of ExchangeLink, SalesLink, ServiceLink and LoyaltyLink products to enable the connectivity, enrollment, reconciliation, eligibility, subsidy and premium billing, member services and renewals for over 5.0 million members, including 2.4 million members on public exchanges and over 1.2 million members on private exchanges. HPS connects 6 of the nation’s largest insurers to public and state exchanges in 39 states and has a market share of 21%.

Ortonville Area Health Services

Ortonville Area Health Services is a healthcare system that includes Ortonville Hospital, Northridge Residence (nursing home), Northside Medical Clinic, Clinton Clinic, and OAHS Home Health Agency. They offer a broad scope of services to keep you and y...

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.